Goksel and colleagues 48 revealed that FRAT1 expression is significantly upregulated in CD133+ CD44+ prostate cancer stem cells and FRAT1 overexpression activates Wnt/β-catenin signaling pathway by inducing β-catenin/TCF activity. This evidence concerns the gene HNF4A and prostate carcinoma.